Nonalcoholic steatohepatitis (NASH) is part of a spectrum of conditions collectively referred to as nonalcoholic fatty liver disease (NAFLD). 3 result found: ICD-10-CM Diagnosis Code K75. Non-alcoholic steatohepatitis. The liver is an important organ in the metabolism (handling) of fat. When using code K70. Save Saved. 81. The definitive diagnosis of non-alcoholic steatohepatitis was established using hepatic biopsy. The tissue sample is looked at in a lab for signs of inflammation and scarring. Nonalcoholic steatohepatitis (NASH) - instead, use code K75. 1. HCCs; ICD-11 NEW; SNOMED CT NEW; ICD-9-CM;K70. Background. In Asian countries, lifestyle changes have led to gradually increasing numbers of NAFLD and nonalcoholic steatohepatitis (NASH),. Test: 550960. Search online 72,000+ ICD-10 codes by number, disease, injury, drug, or keyword. The control group included the rest of adult individuals without discharge records of NASH. 2019;101:154005. Applicable To. Our aims were to create and validate a noninvasive prediction model for NASH. ICD 9 Codes: 571. 0. ICD 9 Codes: 571. 81 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Opsi terapi Non-alcoholic Fatty Liver Disease (NAFLD) dan Non-alcoholic Steatohepatitis (NASH) saat ini dapat menggunakan pendekatan farmakologi dan nonfarmakologi. Access to this feature is available in the following products: Find-A-Code Essentials. It accounts for about 20% of nonalcoholic steatohepatitis cases. The 2024 edition of ICD-10-CM K74. 3, and V79. Showing 1-25: ICD-10-CM Diagnosis Code K70. K75. The following code (s) above K70. 00 - K74. Chronic hepatitis due to fatty liver; Fatty liver disease; Fatty liver disease, nonalcoholic; Hepatitis, chronic, due to fatty liver disease; Non-alcoholic fatty liver; Steatosis of liver; nonalcoholic steatohepatitis (NASH) (K75. 9,10 Nonalcoholic steatohepatitis is also fuelingNon-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease that affects approximately one-quarter of the global adult population, posing a significant threat to human health with wide-ranging social and economic implications. 08. 9 million patients in 2030 (~1/3 of the. In the United States, about 100 million people have NAFLD. 571. 1 : K00-K95. 41. 9 contain annotation back-references. Liver Transplant Program. NAFLD is subdivided into nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). ICD-10-CM Coding Rules. Other inflammatory liver diseases (K75) Nonalcoholic steatohepatitis (NASH) (K75. The Hospital Discharge Abstract Database (DAD) was used to. MS-DRG Mapping . K74. This is the American ICD-10-CM version of K70. Nonalcoholic steatohepatitis is strongly associated with overweight or obesity and the metabolic syndrome. Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis. K75. The existing literature regarding the relationship between OSA and nonalcoholic steatohepatitis (NASH) is conflicting. This is the American ICD-10-CM version of K74. 1 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 571. 51 - other international versions of ICD-10 K71. Although noninvasive clinical scores and image-based diagnosis. Scan this QR code to be taken directly to the website. Nonalcoholic steatohepatitis; Steatohepatitis; Steatohepatitis (fatty inflammation of liver); code, if applicable, hepatic fibrosis (K74. K75. Nonalcoholic steatohepatitis (NASH) is a type of nonalcoholic fatty liver disease (NAFLD). NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; NFS, NAFLD fibrosis score, NLP, natural language processing. Alcoholic fatty liver. The need for an effective treatment is both clear and urgent, yet in the absence of proven therapies, treatment is directed toward weight loss and comorbidity management. BMI indicates body mass index (calculated as weight in kilograms divided by height in meters squared); NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis. This was a retrospective, cohort study among Medicare beneficiaries. 11 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. K75. The name of the type of pathology speaks for itself - nonalcoholic steatohepatitis, that is, the source of. At present, clinical coding of this diagnosis requires the combination of two imprecise codes: K74. [1] There are 2 main types of fatty liver disease (FLD): Metabolic Dysfunction Associated Steatotic. The 2024 edition of ICD-10-CM K71. 51 became effective on October 1, 2023. Clinical background. ICD-10-CM Codes;. 81 [convert to ICD-9-CM] Nonalcoholic steatohepatitis (NASH) Nonalcoholic steatohepatitis; Steatohepatitis; Steatohepatitis (fatty inflammation of liver); code, if applicable, hepatic fibrosis (K74. The main treatment option for steatohepatitis is lifestyle modification. The ICD-9-CM code of NAFLD is 571. ICD-10-CM Diagnosis Code K75. 4 Peliosis hepatis K76. 6. The liver makes and exports fat to other parts of the body. 41 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2024 edition of ICD-10-CM K75. doi: 10. 3. 0-1. Type 2 Excludes. Non-alcoholic steatohepatitis (NASH) is pathologically characterized by hepatic steatosis, hepatocyte ballooning, lobular and hepatic inflammation, and interstitial fibrosis 1,2. K75 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail. Diseases of liver. 0 ‘Fatty (change of) liver, not elsewhere classified (non-alcoholic fatty liver disease)’. First discovered in 1980, non-alcoholic steatohepatitis (NASH) is a type of fatty liver disease characterized by excessive liver fat accumulation, hepatic inflammation and fibrosis ( Ludwig et al. Search Page 1/1: K7581. The 2024 edition of ICD-10-CM K74. et al. 16 More than 99% of deaths in. NASH/NAFLD is the most common chronic liver disease. Often there are no or few symptoms. You may have no symptoms in the early stages of NASH. Myeloperoxidase-Sensitive T 1 and T 2 Switchable MR Imaging for Diagnosis of. 1Alcoholic hepatitis. 0 may differ. This is the American ICD-10-CM version of K70. This is the American ICD-10-CM version of K74. Lancet Gastroenterol. Background: The diagnosis of NASH needs a liver biopsy, an invasive procedure that is not frequently accepted by patients. Code History. NAFLD/NASH cirrhosis may also attract code K74. Our large population database results emphasize that there is a significant association between OSA and NASH. 2021 Apr;9(8):729. K75. Download references. Hepatitis, unspecified. Methods:. Definition & Facts. Nonalcoholic fatty liver disease. 60 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. NON-BILLABLE | ICD-10 from 2011 - 2016. Nonalcoholic fatty liver disease is a spectrum of liver diseases composed of nonalcoholic fatty liver and nonalcoholic steatohepatitis (NASH). NAFLD is a fatty infiltration of the liver and the first pathological step for nonalcoholic steatohepatitis (NASH), a. 81 for Nonalcoholic steatohepatitis (NASH) is a medical classification as. ICD-10-CM Index; ICD-10-CM External Causes Index; Table of Drugs; Table of Neoplasms; Conversion; DRG; Rules . The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance From the American. 89 Other specified inflammatory liver diseases; K75. Codes . Both NAFLD and NASH are characterized by identification of > 5% hepatic steatosis in the absence of excessive alcohol consumption and other etiologies []. Article PubMed Google ScholarNon-alcoholic fatty liver disease (NAFLD) is defined as ectopic lipid accumulation in the liver in the absence of excessive alcohol intake or other attributable cause; 25% of the world’s. There are two types; non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH), with the latter indicating the presence of further liver inflammation. People typically develop one type of NAFLD or the other, although sometimes people with one form are later diagnosed with the other form of NAFLD. Nonalcoholic, fatty liver disease (NAFLD) is defined as the ectopic accumulation of fat in the liver (hepatic steatosis) when no other. excessive alcohol consumption, medications, Wilson disease, or disorders of lipid metabolism) [Citation 1]. Nonalcoholic fatty liver disease, or NAFLD, refers to the buildup of excess fat in the liver. NAFLD may progress to cirrhosis and is likely an important cause of cryptogenic cirrhosis [ 1,2 ]. Evidence of steatohepatitis included a steatohepatitis NLP affirmation. S1238 Strategy of Combined ICD Codes and MELD Score Yields High Prevalence of Individuals With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis That Are Eligible for Clinical Trials. 1 - other international versions of ICD-10 K70. K74. 2 Alcoholic cirrhosis of liver convert 571. During a biopsy, your doctor will insert a needle between your ribs into your liver to collect a small sample of liver tissue for laboratory testing. 650-498-7878. Hepatic fibrosis. In the ICD-10-AM, two codes may be used to record NAFLD/NASH: K75. 2011 Jun;54(6):1224-9. 0-) ICD-10-CM Diagnosis Code K76. This entity has not been described in pregnant women and could have obstetrical repercussions. Informed Consent Statement. 81 [convert to ICD-9-CM] Nonalcoholic steatohepatitis (NASH) Nonalcoholic steatohepatitis; Steatohepatitis; Steatohepatitis (fatty inflammation of liver); code, if applicable, hepatic fibrosis (K74. 0 - fatty liver degeneration, not classified elsewhere. Two types of NAFLD are nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). 0 - fatty (change of) liver, not. NAFL is defined as the presence of 5% HS without evidence. 8. 3), those with human immunodeficiency virus infection and infectious hepatitis (042 and 573. Helpline 1-800-465-4837ICD-9-CM Diagnosis Codes; ICD-9-Vol-3 Procedure Code; Search All Data; 2023/2024. It includes a spectrum of liver damage ranging from simple steatosis to nonalcoholic steatohepatitis (NASH), advanced fibrosis, and rarely, progression to cirrhosis []. 0; Other cirrhosis of liver – K74. The lack of consensus on definitions threatens the comparability and generalizability of. We assess the impact of having NAFLD on adverse clinical outcomes and all-cause mortality for people with CKD. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Bookshelf ID: NBK470243 PMID: 29262166. Equivalent ICD-9 Code GENERAL EQUIVALENCE MAPPINGS (GEM) 571. NASH account for 20–25% of NAFLD patients [], and its diagnosis is important owing to its. ICD-9: 571. This assay currently is not available in New York state. A silent disease with no symptoms or mild symptoms such as tiredness and fatigue in early stages. Cirrhosis is an important factor for liver-related morbidity and mortality in patients with NAFLD. There has been an increased interest in non-alcoholic fatty liver disease (NAFLD), and its advanced stage, non-alcoholic steatohepatitis (NASH) because of their increasing impact on global health (). It is the most common form of chronic liver disease, affecting about 25% of the world's population. Nonalcoholic steatohepatitis (NASH) is the inflammatory form of nonalcoholic fatty liver disease (NAFLD). In the United States, the number of NAFLD cases is rapidly expanding, and is expected to reach 100. Nonalcoholic steatohepatitis (NASH) ICD-10 codes not covered for indications listed in the CPB (not all-inclusive): K74. 0. NASH is a serious condition in which fat replaces healthy liver tissue in people who consume little or no alcohol. Chronic hepatitis c with stage 3 fibrosis; Chronic hepatitis c, stage 3 fibrosis; Hepatic fibrosis stage 3; underlying liver disease, such as:; nonalcoholic steatohepatitis (NASH) (K75. However, because this approach has several limitations,. It is the most common liver disease in the United States. 30 [convert to ICD-9-CM] Alcoholic cirrhosis of liver without ascites. This is the first study using the ICD-10-CM code with a specific search code for NASH. 6 may differ. 2024 ICD-10-CM Range K00-K95. Cryptogenic cirrhosis is cirrhosis of uncertain etiology that lacks definitive clinical and histological criteria for a specific disease[1]. Diagnosis and classification of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis:. NAFLD is most often managed in. 1 Up to one in four patients with NAFLD may have non-alcoholic steatohepatitis (NASH), which is associated with significant. 81 is VALID for claim submission. 0 may differ. 5 (Cirrhosis of liver without mention of alcohol), 571. 0 may differ. This classification algorithm was superior to an algorithm using ICD-9 data alone with AUC of 0. 1 became effective on October 1, 2023. Learn more about how we diagnose NASH, including blood tests and imaging studies. This DC applies to chronic liver dieseases, exluding cirrhosis. We identified the diagnosis of HCC in both study and control groups. A practical approach. Background . e. Nonalcoholic steatohepatitis (NASH), a more serious form of the disease, occurs when, along with the fat build up, there is inflammation and subsequent irreversible damage to the liver. 401-421-3185. [2] Patients typically have a history of at least 10 years of heavy alcohol intake, typically 8-10 drinks per day. 69 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 0Nonalcoholic fatty liver disease (NAFLD) is the most common cause of abnormal liver enzymes in both adults and children. Metabolic dysfunction-associated steatohepatitis (MASH) is the replacement term for NASH. K75. 1016/j. 8 should only be used for claims with a date of service on or before September 30, 2015. 0)Nonalcoholic fatty liver disease (NAFLD) is the most common cause of abnormal serum aminotransferase levels in both developed and developing countries. This is the American ICD-10-CM version of K74. Zhang Y, Xing J, Liu L, Qiao F, Li J, et al. 2008 ICD-9-CM Diagnosis Code 571. -) Hepatic ascites and chronic active hepatitis due to toxic liver disease. Nonalcoholic steatohepatitis (NASH) is a common but underappreciated liver disease. 3 to ICD-10-CM. This data is used to determine if a newborn screening is recommended federally or. 0001) and leads to the creation of a new independent. 2174/1381612825666190117102111. ICD-9-CM Diagnosis Codes; ICD-9-Vol-3 Procedure Code; Search All Data; 2023. [1][2][3] Although the exact cause of cryptogenic cirrhosis is unknown, there are correlations that non. 8% of the total causes of death from chronic liver disease ( Golabi et al. Yellowing of the skin and eyes ( jaundice) Spider-like blood vessels just beneath your skin’s surface. 81 ICD-10 code K75. Nonalcoholic steatohepatitis (NASH) is the progressive form of nonalcoholic fatty liver disease (NAFLD), defined as the presence of ≥ 5% hepatic steatosis with inflammation and ballooning of hepatocytes, regardless of hepatic fibrosis []. Learn what factors determine a diagnosis for NASH. The doctor might order several tests to confirm a diagnosis of steatohepatitis. This is the American ICD-10-CM version of K71. 8 ICD-9 Billable. steatosis with lobular inflammation and hepatocellular ballooning) [Citation 18] were also accepted, but not required, for the ICD-10 code to be considered valid. Noninvasive Assessment of Nonalcoholic Steatohepatitis (NASH) NASH is a serious condition that can progress to cirrhosis and its complications including portal hypertension and hepatocellular carcinoma [6, 12, 13]. 9 may differ. – ICD-9 diagnosis code 571. 44 Thus, taking a liver biopsy cannot be considered a screening. Perakakis N, Polyzos SA, Yazdani A, et al. It affects an estimated 20% of the general population, based on cohort studies of varying size and heterogeneous selection. (non-alcoholic steatohepatitis: NASH), which can progress to cirrhosis and hepatocellular carcinoma. (1,2). 3 result found: ICD-10-CM Diagnosis Code K75. 0): Nonalcoholic, fatty liver disease (NAFLD) is defined as the ectopic accumulation of fat in the liver (hepatic steatosis) when no other causes of secondary liver fat accumulation are present. 4 Chronic hepatitis. Alcoholic cirrhosis with ascites; Ascites due to alcoholic cirrhosis. Alcoholic fatty liver. Fax. Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) is associated with metabolic syndrome and is rapidly increasing globally with the increased prevalence of obesity. Background. Biomarker Qualification Submission DDTBMQ000112: Imaging Biomarkers for Diagnosis of Nonalcoholic Steatohepatitis (FDA, 2021). The 2024 edition of ICD-10-CM K74. 1097/MEG. 0 should only be used for claims with. This is the first study using the ICD-10-CM code with a specific search code for NASH. K73 Chronic hepatitis, not elsewhere classified. 3 Alcoholic liver damage, unspecified convert 571. NASH is diagnosed when examination of the tissue with a microscope. 8 ‘Other specified inflammatory liver diseases (non-alcoholic steatohepatitis)’ or K76. Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis. Up to 1 in 4 individuals with NAFLD have nonalcoholic steatohepatitis, which is associated with significant morbidity and mortality due to complications of liver cirrhosis, hepatic. 0 became effective on October 1, 2023. ICD-10: K76. MS-DRG Mapping . 2 Information Way . K71. Alcoholic cirrhosis with ascites; Ascites due to alcoholic cirrhosis. 81) Hierarchy Tree View ICD-10; YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY. Free, official information about 2010 (and also 2011-2015) ICD-9-CM diagnosis code 571. Bethesda, MD 20892–3570 . 0. Clinics for Diagnosis. 6 ‘Other and unspecified cirrhosis of liver’. GI Nutrition Services. 81), whereas the ICD-9 codes are more ambiguous and could represent either NAFL or NASH. Zoli M, Melchionda N: Metformin in non-alcoholic steatohepatitis. K72. Clinical background. 0 ‘Fatty (change. A 70-year-old patient with a history of nonalcoholic steatohepatitis (NASH) cirrhosis complicated by hepatic encephalopathy and diabetes presented to the emergency department (ED). 9 [convert to ICD-9-CM] Non-alcoholic fatty liver disease (NAFLD) consists of non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH). Code First. Methods Annual deaths and age-standardized death rates (ASDR) for NALC from 1990 to 2019 were collected from the. The 2024 edition of ICD-10-CM K71. Steatohepatitis, nonalcoholic; Steatosis of liver; Yellow atrophy of liver, chronic; Applies To. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024. Download the app!. Nonalcoholic fatty liver disease (NAFLD) is the primary cause of chronic liver disease in the United States, afflicting an estimated 80 to 100 million Americans. 0 – other international versions of ICD-10 K76. ICD-10-CM 2023 Coding Guide™ from Unbound Medicine. The organ helps break down food, store energy, filter waste products, and remove toxins. NASH has an estimated prevalence of 3% to 5% in the US general population. In 2013, NASH became the second leading. Non-alcoholic fatty liver disease (NAFLD) is a common, progressive liver disease strongly associated with the metabolic syndrome. 0 became effective on October 1, 2018. Cryptogenic cirrhosis accounts for nearly 5% to 30% of cases of cirrhosis and nearly 10% of liver transplants. 650-736-5555. ” A date range of January 1, 2000, to May 1, 2015, was used for the search. Both are characterized by hepatic steatosis, or abnormal retention of lipids in the liver, in the absence of excessive alcohol use, but NASH is associated with hepatocyte ballooning. Clinics for Nonalcoholic Steatohepatitis (NASH) GI Nutrition Services. | ICD-10 from 2011 - 2016 K75. 69 became effective on October 1, 2023. The 2024 edition of ICD-10-CM K76 became effective on October 1, 2023. Chronic hepatitis c with stage 3 fibrosis; Chronic hepatitis c, stage 3 fibrosis; Hepatic fibrosis stage 3; underlying liver disease, such as:; nonalcoholic steatohepatitis. NASH is a severe form of nonalcoholic fatty liver disease characterized by chronic inflammation and liver cell injury. org There are two forms of NAFLD: nonalcoholic fatty liver (NAFL), defined as 5% or greater hepatic steatosis without hepatocellular injury or fibrosis, and nonalcoholic steatohepatitis (NASH. 0 - other international versions of ICD-10 K74. Fatty replacement and damage to the hepatocytes not related to. Some people with NAFLD can get. 571. ICD Code K70. 8: Chronic liver dis NEC: 573. Applicable To. You may feel tired or have pain in the upper right side of your abdomen, where your liver is. Steatohepatitis (also known as fatty liver disease) is a type of liver disease, characterized by inflammation of the liver with concurrent fat accumulation in liver (steato-, meaning "fat", hepatitis, meaning "inflammation of the liver"). Our objective was to validate coding algorithms for AH using a hospitalization database. HCC Plus. Abstract. Int. The diagnosis of nonalcoholic fatty liver disease is based on exclusion of other etiologies of hepatic steatosis, such as alcohol use, and supportive laboratory tests and imaging. 81) ICD-10-CM Diagnosis Code K76. ) and global population. 5. Weight loss for no clear reason. 1. g. 81. 9, 571. Equivalent. Short description: Chronic liver dis NEC. This study aimed to examine the association between the Energy-adjusted Diet Inflammatory Index (E-DII) score and severe NAFLD using UK Biobank. 2% of non-drinkers and 0. The main characteristic of NAFLD is considered that the excessive fat is accumulated and. 0, 571. When treating NASH, doctors may recommend: aiming for a weight loss of at least 5–10% through exercise and. 41 became effective on October 1, 2023. Search for: Translate. (ICD-9 codes 401–405), defined as a blood pressure ≥ 130/85 mmHg, (2) diabetes mellitus (DM; ICD-9 code 250. et al. , 2005; Diehl and Day, 2017 ). 6%). K76 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail. NAFLD comprises, a benign non-alcoholic fatty liver (NAFL), and the more serious non-alcoholic. 81 K75. 6), and ≥ 3 counts of nonalcoholic fatty liver (571. The field of nonalcoholic fatty liver disease (NAFLD) and its progressive form, nonalcoholic steatohepatitis (NASH), has, despite the challenges of the coronavirus disease 2019 (COVID-19) pandemic. 2% of the total cohort and in 29. It encompasses conditions from simple steatosis (NAFL), believed to be associated with slow disease progression, to the more severe and progressive form. The 2024 edition of ICD-10-CM K72. K72 Hepatic failure, not elsewhere classified. Background Chronic kidney disease (CKD) and non-alcoholic fatty liver disease (NAFLD) frequently co-exist. 0 may differ. Healthcare Provider Information about Non-Alcoholic Steatohepatitis (NASH) NASH is a chronic liver disease characterized by liver cell injury (hepatocellular ballooning) and inflammation as a result of fatty accumulation (steatosis) seen in at least 5% of hepatocytes. 81) ICD-10-CM Diagnosis Code K76. 8 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 571. 3 ICD-9 Billable. The association between obstructive sleep apnea and non-alcoholic steatohepatitis: a retrospective nationwide inpatient sample analysis Diagnosis: Inclusion ICD-9 code: In the ICD-9 branch of chronic liver disease (571) we will include 571. Helpline 1-800-465-4837. (ICD-9) codes. 81 is a valid billable ICD-10 diagnosis code for Nonalcoholic steatohepatitis (NASH) . (15) A recent meta-analysis estimated that the pooled The algorithm with the highest PPV of 100% on internal validation and 92% on external validation consisted of ≥ 3 counts of cirrhosis, no mention of alcohol (571. No significant differences were observed regarding metabolic syndrome, type 2 diabetes mellitus, hypertension, dyslipidemia, rs662 polymorphism allele frequencies,. 6 contain annotation back-references that may be applicable to K74. Learn what factors determine a diagnosis for NASH. For instance, no clear guidance exists on how to define the progression of NAFLD to cirrhosis, (i. Nonalcoholic steatohepatitis affects 3% to 6% of the US population, is more prevalent in patients with metabolic disease and obesity, progresses to cirrhosis in approximately 20% of cases, and is associated with increased rates of liver. This ICD-10 code translates to more than one ICD-9 code: 571. In most clinical trials focusing on precirrhotic nonalcoholic steatohepatitis (NASH), a liver biopsy is required for confirmation of diagnosis, staging fibrosis, and grading steatohepatitis activity. K77 Liver disorders in diseases classified elsewhere. 9 may differ. 89 Other specified inflammatory liver diseases; K75. It is currently the most common. Billable Thru Sept 30/2015. NASH is characterized by steatosis accompanied by hepatocyte. 8 should only be used for claims with a date of service on or before September 30, 2015. Nonalcoholic fatty liver disease (NAFLD) Type 1 Excludes. Metaboli. Includes Excludes I Excludes II Notes From Section K70-K77:. Nonalcoholic steatohepatitis (NASH) is a type of nonalcoholic fatty liver disease (NAFLD).